NASDAQ: GNPX
Genprex Inc Stock Ownership - Who owns Genprex?

Insider buying vs selling

Have Genprex Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Stanley BergerChief Medical Officer2025-06-304,500$0.23
$1.03kSell
Ryan M. ConferPresident CEO and CFO2025-06-305,775$0.23
$1.32kSell
Mark Stanley BergerChief Medical Officer2025-02-18585$0.41
$239.85Sell
Ryan M. ConferPresident CEO and CFO2025-02-18395$0.41
$161.95Sell

1 of 1

GNPX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GNPX insiders and whales buy or sell their stock.

GNPX Shareholders

What type of owners hold Genprex Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christy M. Nance10.81%3,006,298$802.68kInsider
Jack A. Roth5.25%1,461,813$390.30kInsider
Catherine M. Vaczy0.95%265,000$70.76kInsider
Hermant Kumar0.72%200,000$53.40kInsider
Geode Capital Management LLC0.30%83,695$22.35kInstitution
Hightower Advisors LLC0.29%79,500$21.23kInstitution
Hrt Financial LP0.17%46,720$12.47kInstitution
Ubs Group Ag0.15%42,686$11.40kInstitution
Two Sigma Securities LLC0.15%42,174$11.26kInstitution
Vietan Hoan Ly0.13%36,067$9.63kInsider

1 of 3

GNPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GNPX1.38%18.31%Net SellingNet Selling
CLDI17.17%58.63%Net Buying
CVM26.72%73.28%Net BuyingNet Buying
CLRB55.77%44.23%Net Buying
GOVX0.46%99.54%Net BuyingNet Buying

Genprex Stock Ownership FAQ

Who owns Genprex?

Genprex (NASDAQ: GNPX) is owned by 1.38% institutional shareholders, 18.31% Genprex insiders, and 80.31% retail investors. Christy M. Nance is the largest individual Genprex shareholder, owning 3.01M shares representing 10.81% of the company. Christy M. Nance's Genprex shares are currently valued at $811.70k.

If you're new to stock investing, here's how to buy Genprex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.